FRANCZYK, THADDEUS S,WAGNER, ROLF,TUFANO, MICHAEL D,STEWART, KENT D,ROCKWAY, TODD W,RANDOLPH, JOHN T,PRATT, JOHN K,MOTTER, CHRISTOPHER E,MARING, CLARENCE J,LONGENECKER, KENTON L,LIU, YAYA,LIU, DACHUN
申请号：
NZ58472008
公开号：
NZ584720A
申请日:
2008.09.17
申请国别(地区):
NZ
年份:
2012
代理人:
摘要：
Disclosed are Uracil or Thymine derivatives of formula (I) examples of which are: (E)-N-(4-(3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxystyryl)phenyl)methanesulfonamide； (E)-N-(4-(3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxystyryl)phenyl)methanesulfonamide (Z)-N-(4-(2-(3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-1(2H)-yl)-2-methoxyphenyl)-1-chlorovinyl)phenyl)methanesulfonamide； (E)-1-(3-tert-butyl-5-(4-fluorostyryl)-4-methoxyphenyl) dihydropyrimidine-2,4(1H,3H)-dione； The compounds are for use in treating Hepatitis C
